Ray Dalio acquired 21.5 Thousand Haemonetics shares worth $1.65 Million. That's 0.01% of their equity portfolio (467th largest holding). The first Haemonetics trade was made in Q2 2021. Since then Ray Dalio bought shares six more times and sold shares on nine occasions. The stake costed the investor $1.45 Million, netting the investor a gain of 14% so far.